Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44CA233128-03
Application #
9919322
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Franca-Koh, Jonathan C
Project Start
2018-09-14
Project End
2021-04-30
Budget Start
2020-05-01
Budget End
2021-04-30
Support Year
3
Fiscal Year
2020
Total Cost
Indirect Cost

  Institution

Name
Nanovalent Pharmaceuticals, Inc.
Department
Type
DUNS #
788166986
City
Bozeman
State
MT
Country
United States
Zip Code
59715